Black Rock Inc. Vivos Therapeutics, Inc. Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.18 - $0.52 $232 - $670	-1,290 Reduced 55.44%	1,037 $0
Q2 2023 Aug 11, 2023	SELL	$0.31 - $0.55 $14,359 - $25,477	-46,322 Reduced 95.22%	2,327 $1,000
Q1 2023 May 12, 2023	BUY	$0.32 - $1.88 $493 - $2,898	1,542 Added 3.27%	48,649 $16,000
Q4 2022 Feb 13, 2023	BUY	$0.35 - $20.75 $359 - $21,331	1,028 Added 2.23%	47,107 $18,000
Q3 2022 Nov 14, 2022	SELL	$0.83 - $21.25 $1,066 - $27,306	-1,285 Reduced 2.71%	46,079 $30,000
Q2 2022 Aug 12, 2022	SELL	$1.12 - $2.18 $863 - $1,680	-771 Reduced 1.6%	47,364 $60,000
Q1 2022 May 12, 2022	SELL	$1.63 - $3.63 $3,770 - $8,396	-2,313 Reduced 4.58%	48,135 $129,000
Q4 2021 Feb 10, 2022	BUY	$2.25 - $4.11 $3,471 - $6,341	1,543 Added 3.16%	50,448 $114,000
Q3 2021 Nov 09, 2021	BUY	$2.71 - $5.9 $95,278 - $207,432	35,158 Added 255.75%	48,905 $198,000
Q2 2021 Aug 11, 2021	BUY	$4.83 - $9.67 $66,398 - $132,933	13,747 New	13,747 $68,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.